학술논문

Do Transtibial Amputations Outperform Amputations of the Hind- and Midfoot Following Severe Limb Trauma?: A Secondary Analysis of the OUTLET Study
Document Type
Academic Journal
Author
Fram, Brianna R.Bosse, Michael J.Odum, Susan M.Reider, LisaGary, Joshua L.Gordon, Wade T.Teague, DavidAlkhoury, DanaMacKenzie, Ellen J.Seymour, Rachel B.Karunakar, Madhav A.Fox, W. EverettHsu, Joseph R.Kempton, LaurenceRobinson, Katherine SampleSims, Stephen H.Churchill, ChristineTeasdall, Robert D.Carroll, Eben A.Scott, Aaron T.Halvorson, Jason J.Pilson, HollyGoodman, James BrettHolden, Martha B.McAndrew, Christopher M.Gardner, Michael J.Miller, Anna N.Hughes, Amanda SpraggsStinner, Daniel J.Rivera, Jessica C.Osborn, Patrick M.Nadeau, Jason T.Howes, CameronSchenker, Mara L.Mir, HassanTaylor, Benjamin C.Schmidt, Andrew H.Mullis, Brian H.Shively, Karl D.Sorkin, Anthony T.Virkus, WalterKonda, Sanjit R.Choo, AndrewMunz, John W.Boutte, SterlingBreslin, Mary A.Toledano, James E.Langford, Joshua RobertHorne, AndreaO’Toole, Robert V.Boulton, ChristinaManson, TheodoreNascone, JasonPollak, Andrew N.Sciadini, Marcus F.Degani, YasminHowe, Andrea L.Zych, Gregory A.Cannada, Lisa K.Dawson, Sarah A.Jones, Clifford B.Sietsema, Debra L.Miclau, TheodoreMorshed, SaamWilken, Jason M.Bergin, Patrick F.Graves, Matt L.Spitler, Clay A.Jones, LaRita C.Ertl, WilliamMoloney, Gele B.Evans, Andrew R.Weiss, David B.Yarboro, Seth R.Lester-Ballard, VeronicaMcVey, Eric D.Firoozabadi, RezaAgel, JulieObremskey, WilliamArcher, Kristin R.Burgos, Eduardo J.Gajari, VamshiRodriguez-Buitrago, AndresTummuru, Rajesh R.Trochez, Karen M.D’Alleyrand, Jean-Claude G.Castillo, Renan C.Allen, Lauren E.Carlini, Anthony R.
Source
The Journal of Bone and Joint Surgery. Mar 21, 2024
Subject
Language
English
ISSN
0021-9355
Abstract
BACKGROUND:: The purpose of this study was to compare 18-month clinical and patient-reported outcomes between patients with severe lower-limb injuries treated with a transtibial amputation or a hind- or midfoot amputation. Despite the theoretical benefits of hind- and midfoot-level amputation, we hypothesized that patients with transtibial amputations would report better function and have fewer complications. METHODS:: The study included patients 18 to 60 years of age who were treated with a transtibial amputation (n = 77) or a distal amputation (n = 17) and who were enrolled in the prospective, multicenter Outcomes Following Severe Distal Tibial, Ankle, and/or Foot Trauma (OUTLET) study. The primary outcome was the difference in Short Musculoskeletal Function Assessment (SMFA) scores, and secondary outcomes included pain, complications, amputation revision, and amputation healing. RESULTS:: There were no significant differences between patients with distal versus transtibial amputation in any of the domains of the SMFA: dysfunction index [distal versus transtibial], 31.2 versus 22.3 (p = 0.13); daily activities, 37.3 versus 26.0 (p = 0.17); emotional status, 41.4 versus 29.3 (p = 0.07); mobility, 36.5 versus 27.8 (p = 0.20); and bother index, 34.4 versus 23.6 (p = 0.14). Rates of complications requiring revision were higher for distal amputations but not significantly so (23.5% versus 13.3%; p = 0.28). One distal and no transtibial amputees required revision to a higher level (p = 0.18). A higher proportion of patients with distal compared with transtibial amputation required local surgical revision (17.7% versus 13.3%; p = 0.69). There was no significant difference between the distal and transtibial groups in scores on the Brief Pain Index at 18 months post-injury. CONCLUSIONS:: Surgical complication rates did not differ significantly between patients who underwent transtibial versus hind- or midfoot amputation for severe lower-extremity injury. The average SMFA scores were higher (worse), although not significantly different, for patients undergoing distal compared with transtibial amputation, and more patients with distal amputation had a complication requiring surgical revision. Of note, more patients with distal amputation required closure with an atypical flap, which likely contributed to less favorable outcomes. LEVEL OF EVIDENCE:: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.